GSK (NYSE:GSK) Chief Financial Officer Julie Brown outlined the company’s growth strategy, launch priorities and cost-savings plans during a discussion with Bank of America analyst Sachin Jain following the company’s recent capital markets day. Brown said GSK’s strategic portfolio review identified seven major assets across roughly 18 indications for accelerated development, with particular emphasis on […]